Innospec Inc. (NASDAQ:IOSP) Shares Sold by Parallel Advisors LLC

Parallel Advisors LLC lowered its stake in shares of Innospec Inc. (NASDAQ:IOSPFree Report) by 20.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 518 shares of the specialty chemicals company’s stock after selling 130 shares during the period. Parallel Advisors LLC’s holdings in Innospec were worth $64,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in IOSP. Quest Partners LLC purchased a new stake in shares of Innospec during the fourth quarter worth about $304,000. UBS Group AG grew its holdings in Innospec by 204,935.7% in the fourth quarter. UBS Group AG now owns 57,410 shares of the specialty chemicals company’s stock valued at $7,075,000 after purchasing an additional 57,382 shares during the period. Norges Bank acquired a new stake in shares of Innospec during the 4th quarter worth $25,925,000. AMG National Trust Bank boosted its holdings in Innospec by 30.7% in the fourth quarter. AMG National Trust Bank now owns 11,595 shares of the specialty chemicals company’s stock valued at $1,429,000 after acquiring an additional 2,721 shares during the last quarter. Finally, Panagora Asset Management Inc. increased its stake in Innospec by 26.1% during the fourth quarter. Panagora Asset Management Inc. now owns 49,113 shares of the specialty chemicals company’s stock worth $6,053,000 after acquiring an additional 10,156 shares during the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Stock Down 1.3 %

NASDAQ IOSP opened at $129.23 on Friday. The stock has a market cap of $3.22 billion, a PE ratio of 21.94 and a beta of 1.14. The business has a 50 day moving average price of $125.65 and a two-hundred day moving average price of $121.30. Innospec Inc. has a fifty-two week low of $95.69 and a fifty-two week high of $133.71.

Innospec (NASDAQ:IOSPGet Free Report) last released its quarterly earnings results on Thursday, May 9th. The specialty chemicals company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.64 by $0.11. The business had revenue of $500.20 million for the quarter, compared to analysts’ expectations of $508.15 million. Innospec had a return on equity of 14.22% and a net margin of 7.60%. Sell-side analysts anticipate that Innospec Inc. will post 6.7 EPS for the current fiscal year.

Innospec Dividend Announcement

The company also recently declared a Semi-Annual dividend, which was paid on Friday, May 31st. Investors of record on Monday, May 20th were paid a $0.72 dividend. The ex-dividend date of this dividend was Friday, May 17th. This represents a yield of 1.2%. Innospec’s dividend payout ratio (DPR) is 25.81%.

Insider Buying and Selling at Innospec

In related news, SVP Hardy Louis Griffin III sold 525 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $129.78, for a total transaction of $68,134.50. Following the sale, the senior vice president now directly owns 4,523 shares of the company’s stock, valued at approximately $586,994.94. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.35% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Separately, raised shares of Innospec from a “buy” rating to a “strong-buy” rating in a research report on Friday, May 10th.

Check Out Our Latest Report on Innospec

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Articles

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with's FREE daily email newsletter.